Pirtobrutinib,Ibrutinib
eli lilly
['pirto', 'leusm', 'bruin cll-314', 'lymphoma', 'lymsm', 'cll', 'bruin', 'leukemia', 'ibru']
bruin cll-314: a phase 3, open-label, randomized study of pirtobrutinib versus ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. | journal of clinical oncology | trial in progress from #asco2023 #asco23 #cll #leusm #lymsm 
Assistant Professor, UM Sylvester Comprehensive Cancer Center. Physician scientist studying the role of nuclear export and splicing in hematologic cancers.